Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024
30 January 2024 - 12:00AM
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global
provider of life science reagents and services to researchers and
biotech innovators, plans to announce its fourth quarter and full
year 2023 financial and operating results after the market closes
on Thursday, February 22, 2024, and will host a conference call and
webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.
To participate in the conference call by telephone,
dial (888) 596-4144 or (646) 968-2525 and reference Maravai
LifeSciences, Conference ID 4939675. The call will also be
available via live or archived webcast on the "Investors" section
of the Maravai web site at https://investors.maravai.com.
About Maravai Maravai is a leading life
sciences company providing critical products to enable the
development of drug therapies, diagnostics, and novel vaccines and
to support research on human diseases. Maravai’s companies are
leaders in providing products and services in the fields of nucleic
acid synthesis and biologics safety testing to many of the world's
leading biopharmaceutical, vaccine, diagnostics, and cell and gene
therapy companies.
Contact Information:
Deb Hart
Maravai LifeSciences
+ 1 858-988-5917
ir@maravai.com
Maravai LifeSciences (NASDAQ:MRVI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Maravai LifeSciences (NASDAQ:MRVI)
Historical Stock Chart
From Apr 2023 to Apr 2024